Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
09/11/2012 | US8263834 Soybean variety XB31S10 |
09/11/2012 | US8263832 Soybean variety A1016467 |
09/11/2012 | US8263831 Soybean variety A1016054 |
09/11/2012 | US8263830 Soybean variety A1015481 |
09/11/2012 | US8263829 Soybean variety A1015993 |
09/11/2012 | US8263827 Sclerotinia-resistant Brassica |
09/11/2012 | US8263741 Artificial antibody polypeptides |
09/11/2012 | US8263559 Feline granulocyte macrophage colony stimulating factor proteins |
09/11/2012 | US8263412 Long wavelength engineered fluorescent proteins |
09/11/2012 | US8263406 Transforming and embryonic stem cells with vector comprising marker proteins, incubating with hedgehog and/or retinoic acid and recovering nervous system tissues; treating spinal cord or nervous system injury |
09/11/2012 | US8263405 Controllably degradable hydrogel for culturing cells to produce three-dimensionally organized cells |
09/11/2012 | US8263404 Method for enriching rare cell subpopulations from blood |
09/11/2012 | US8263403 Methods and compositions for stem cell self-renewal |
09/11/2012 | US8263402 Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells |
09/11/2012 | US8263401 Adenylyl cyclase antibodies, compositions and uses thereof |
09/11/2012 | US8263400 Method for expanding adult stem cells from blood and compositions and methods for using the same |
09/11/2012 | US8263398 Promoter and viral vector containing the same |
09/11/2012 | US8263394 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides, and uses thereof |
09/11/2012 | US8263376 Lipoxygenase |
09/11/2012 | US8263362 Cytochrome P450S and uses thereof |
09/11/2012 | US8263359 Method and device to fractionate stem cells |
09/11/2012 | US8263349 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof |
09/11/2012 | US8263341 Assays that detect T1R expressing cells |
09/11/2012 | US8263326 Compounds and methods for modulating activation of NF-κB |
09/11/2012 | US8263089 Compounds and methods for treatment and diagnosis of chlamydial infection |
09/11/2012 | US8263085 Gammaretrovirus associated with cancer |
09/11/2012 | US8263067 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy |
09/11/2012 | US8263066 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
09/11/2012 | US8263065 Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
09/11/2012 | US8261749 Augmentation and repair of vocal cord tissue defects |
09/11/2012 | CA2675147C Use of an in vitro hemodynamic endothelial/smooth muscle cell co-culture model to identify new therapeutic targets for vascular disease |
09/11/2012 | CA2510180C Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2 |
09/11/2012 | CA2493588C Functional cardiomyocytes from human embryonic stem cells |
09/11/2012 | CA2489298C Novel antagonists of cxcr3-binding cxc chemokines |
09/11/2012 | CA2451577C Gene delivery vectors with cell type specificity for mesenchymal stem cells |
09/11/2012 | CA2395291C Five-helix protein |
09/11/2012 | CA2343839C Cytokine receptor zalpha11 |
09/11/2012 | CA2272820C An improved method for the production and purification of adenoviral vectors |
09/11/2012 | CA2257247C Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same |
09/07/2012 | WO2012119103A2 Compositions and methods for mobilization of stem cells |
09/07/2012 | WO2012119074A1 Apparatus and method for organizing three-dimensional cell structures using stiffness gradients and sacrificial gels |
09/07/2012 | WO2012118988A1 Direct reprogramming of human fibroblasts to functional neurons under defined conditions |
09/07/2012 | WO2012118857A2 Immunologically modified carbon nanotubes for cancer treatment |
09/07/2012 | WO2012118806A2 Compositions and methods for detecting and treating cancer |
09/07/2012 | WO2012118799A2 Cell culture system |
09/07/2012 | WO2012118349A2 Differentiation and proliferation method for natural killer cells from cd14-positive monocytes |
09/07/2012 | WO2012118305A2 Method for manufacturing allogeneic soft-tissue transplant having autologous stem cell transplanted therein |
09/07/2012 | WO2012118304A2 Device for incubating allogeneic soft tissue implant |
09/07/2012 | WO2012118097A1 Cell sheet having hyaluronic acid production ability and method for producing same |
09/07/2012 | WO2012118092A1 Fusion protein |
09/07/2012 | WO2012117968A1 Method for controlling genesis and/or differentiation of embryo |
09/07/2012 | WO2012117855A1 (nucleic acid)-polysaccharide complex |
09/07/2012 | WO2012117373A1 Genetically modified muscle cells which express neurotrophic factors |
09/07/2012 | WO2012117333A1 Isolation and expansion of adult stem cells, their therapeutic composition and uses thereof |
09/07/2012 | WO2012117254A1 Mammalian haploid embryonic stem cells |
09/07/2012 | WO2012116699A1 Active vitamin d or analogs thereof for use in in vivo or in vitro fertilization |
09/07/2012 | WO2012096461A3 Composition for suspension culturing of stem cells |
09/07/2012 | WO2012078648A3 Novel method of cancer diagnosis and prognosis and prediction of response to therapy |
09/07/2012 | WO2012074117A8 Efficient method for establishing induced pluripotent stem cells |
09/07/2012 | WO2012061637A3 Hsv-1 epitopes and methods for using same |
09/07/2012 | WO2012047354A3 Environmentally sensitive compositions |
09/07/2012 | WO2012014076A3 Liver organoid, uses thereof and culture method for obtaining them |
09/07/2012 | CA2828110A1 Cell culture system |
09/06/2012 | US20120227134 Plants with Increased Yield |
09/06/2012 | US20120227133 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
09/06/2012 | US20120227132 Cell number polynucleotides and polypeptides and methos of use thereof |
09/06/2012 | US20120227131 Transgenic plants with enhanced agronomic traits |
09/06/2012 | US20120227126 Barley cultivar moravian 115 |
09/06/2012 | US20120227125 Cotton Cultivar L-3233 |
09/06/2012 | US20120227124 Cotton Cultivar L-269 |
09/06/2012 | US20120227123 Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline and oxidative conditions |
09/06/2012 | US20120227122 Hybrid artichoke variety nun 4060 ar |
09/06/2012 | US20120227121 Pumpkin hybrid pxt 13067440 iii |
09/06/2012 | US20120227120 Hydrolases, nucleic acids encoding them and methods for making and using them |
09/06/2012 | US20120227118 Mo-1 conditional knock-out non-human animal and uses thereof |
09/06/2012 | US20120226062 Mutant delta-9 elongases and their use in making polyunsaturated fatty acids |
09/06/2012 | US20120226055 Microbial production of 3,4-dihydroxybutyrate (3,4-dhba), 2,3- dihydroxybutyrate (2,3-dhba) and 3-hydroxybutyrolactone (3-hbl) |
09/06/2012 | US20120226023 Cytomegalovirus surface protein complex for use in vaccines and as a drug target |
09/06/2012 | US20120225936 Method for producing triptolide |
09/06/2012 | US20120225933 Regulated expression systems |
09/06/2012 | US20120225928 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
09/06/2012 | US20120225927 Compositions and methods for inhibiting expression of transthyretin |
09/06/2012 | US20120225926 Amphiphilic macromolecules for nucleic acid delivery |
09/06/2012 | US20120225894 Substituted Thienol[2,3-d] pyrimidines as HIV Inhibitors |
09/06/2012 | US20120225883 Compounds for inflammation and immune-related uses |
09/06/2012 | US20120225880 Pyrazole compounds and thiazole compounds as protein kinases inhibitors |
09/06/2012 | US20120225871 Small-molecule modulators of trp-p8 activity |
09/06/2012 | US20120225864 Methods and Compositions for Modulating Tau Levels |
09/06/2012 | US20120225859 Pyrimidine derivatives used as pi-3 kinase inhibitors |
09/06/2012 | US20120225824 Mullerian inhibiting substance (mis) analogues |
09/06/2012 | US20120225814 Hydrogel-based vascular lineage cell growth media and uses thereof |
09/06/2012 | US20120225809 Compounds for treating papilloma virus infection |
09/06/2012 | US20120225485 Methods for producing synthetic surfaces that mimic collagen coated surfaces for cell culture |
09/06/2012 | US20120225484 Human placental collagen compositions, and methods of making and using the same |
09/06/2012 | US20120225483 Microsphere-Containing Cell Aggregate |
09/06/2012 | US20120225482 Mammalian cx3c chemokine antibodies |
09/06/2012 | US20120225481 T cell receptors |
09/06/2012 | US20120225480 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state |
09/06/2012 | US20120225479 Thermostable variants of fibroblast growth factors |
09/06/2012 | US20120225478 Anti-amyloid beta antibodies and their use |